Radiopharmacuticals   |   The Theragenics Solution

The Radiopharmacutical Industry
A Supply Chain in Need

Radiopharmacuticals   |   The Theragenics Solution

The Radiopharmacutical Industry
A Supply Chain in Need

The radiopharmaceutical industry faces a critical challenge: an underdeveloped and fragmented supply chain for radioisotopes. Currently, most radioisotopes are produced using electron beam accelerators or small cyclotrons, which are inadequate for the commercial scale required to meet burgeoning demand.

This reliance on limited production capacities necessitates a complex network of multiple suppliers for radiopharmaceutical companies, creating a decentralized and unpredictable supply chain.

This decentralization leads to several critical issues:

Intermittent Shortages
Fluctuations in isotope production due to technical difficulties, maintenance, or unexpected shutdowns result in frequent supply disruptions, hindering consistent drug production and patient access.
Cost Inefficiency
Decentralized supply chains may reduce cost efficiency due to a lack of economies of scale. This can contribute to higher prices for both drug manufacturers and patients.
Quality Variability
Differences in production processes and quality control standards among suppliers can lead to inconsistent isotope quality, requiring rigorous testing and increasing drug production complexity.
Geographic Limitations
The dispersal of radioisotope suppliers across various regions presents logistical challenges, increasing transportation costs and transit times, ultimately delaying patient access to critical therapies.

These challenges collectively hinder the efficient development and delivery of radiopharmaceuticals, limiting patient access to potentially life-saving treatments.

This decentralization leads to several critical issues:

Supply Disruptions

Fluctuations in isotope production due to technical difficulties, maintenance, or unexpected shutdowns result in frequent supply disruptions, hindering consistent drug production and patient access.

Cost Inefficiency

Decentralized supply chains may reduce cost efficiency due to a lack of economies of scale. This can contribute to higher prices for both drug manufacturers and patients.

Product Consistency

Variations in production methods, locations, and staff can result in differences in isotope quality. This may add complexity to the manufacturing process. 

Geographic Limitations

The dispersal of radioisotope suppliers across various regions presents logistical challenges, increasing transportation costs and transit times, ultimately delaying patient access to critical therapies.

These challenges collectively hinder the efficient development and delivery of radiopharmaceuticals, limiting patient access to potentially life-saving treatments.

Vertical Integration - An Optimized Approach

Theragenics offers a transformative solution to the challenges inherent in the decentralized radioisotope supply chain. Our state-of-the-art manufacturing facility houses an unparalleled 14 cyclotrons, enabling us to produce radioisotopes at a commercial scale previously unattainable.

The Theragenics Solution

By centralizing production and leveraging our vertical integration, Theragenics provides a robust and efficient supply chain. This centralized model offers several key advantages:

The Theragenics Solution

By centralizing production and leveraging our vertical integration, Theragenics provides a robust and efficient supply chain. This centralized model offers several key advantages.

Robust Supply

Robust Supply

Robust Supply

Robust Supply

Robust Supply

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Learn more about our facilities

Lorem ipsum dolor sit amet consectetur adipiscing elit dolor

Robust Supply

Our extensive production capacity ensures a consistent and reliable supply of radioisotopes, eliminating the risk of shortages that plague the decentralized model.

Quality Assurance

Rigorous quality control standards are upheld throughout our entire process, from isotope production to final product shipment, guaranteeing the highest quality materials.

Cost Efficiency

Economies of scale achieved through our centralized operations lead to reduced production costs, ultimately benefiting drug manufacturers and patients alike.

Strategic Partnerships

Theragenics is committed to building strong, collaborative relationships with our partners, offering comprehensive support throughout the commercialization process.

Supply Chain Optimization

By consolidating production, logistics, and distribution into a single location, we streamline the supply chain, reducing lead times and improving overall efficiency.

Robust Supply

Our extensive production capacity ensures a consistent and reliable supply of radioisotopes, eliminating the risk of shortages that plague the decentralized model.

Quality Assurance

Rigorous quality control standards are upheld throughout our entire process, from isotope production to final product shipment, guaranteeing the highest quality materials.

Cost Efficiency

Economies of scale achieved through our centralized operations lead to reduced production costs, ultimately benefiting drug manufacturers and patients alike.

Strategic Partnerships

Theragenics is committed to building strong, collaborative relationships with our partners, offering comprehensive support throughout the commercialization process.

Supply Chain Optimization

By consolidating production, logistics, and distribution into a single location, we streamline the supply chain, reducing lead times and improving overall efficiency.

Robust Supply

Our extensive production capacity ensures a consistent and reliable supply of radioisotopes, eliminating the risk of shortages that plague the decentralized model.

Consistent Quality

Rigorous quality control standards are upheld throughout our entire process, from isotope production to final product shipment, guaranteeing the highest quality materials.

The Theragenics Solution

By centralizing production and leveraging our vertical integration, Theragenics provides a robust and efficient supply chain. This centralized model offers several key advantages.

Strategic Partnerships

Theragenics is committed to building strong, collaborative relationships with our partners, offering comprehensive support throughout the commercialization process.

Cost Efficiency

Economies of scale achieved through our centralized operations lead to reduced production costs, ultimately benefiting drug manufacturers and patients alike.

Supply Chain Optimization

By consolidating operations into a single location, we optimize logistics and distribution, reducing lead times and improving overall efficiency.

Partner with Theragenics

Ready to revolutionize your radiopharmaceutical supply chain? Theragenics offers a proven solution to the challenges facing the industry.

Our centralized model delivers robust supply, cost efficiency, and consistent quality.

Interested in learning more?

Contact us today to learn more about how Theragenics can support your business goals.

Interested in learning more?

Contact us today to learn more about how Theragenics can support your business goals.

;

Our History

Learn how we’re building on over 40 years of medical device innovation.

;

Careers

Ready to join a dynamic team committed to advancing patient care?

Contact Us

Get in touch to learn more about our products and services.